Concepedia

Lindsay Johnson

LJ

Statistics

Publications

4

Citations

282

H-Index

4

Active since

2007

Affiliations

Addenbrooke's Hospital(Current)

Lindsay Johnson is an author at Addenbrooke's Hospital specializing in oncology, medicine, and chemotherapy.

Publications per year

2007–2017

4

Publications

4

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

Peter Barrett‐Lee, Lindsay Johnson, David Cameron et al. · The Lancet · 2009 · 189 citations · Full text

Medicine, Oncology, Pharmacology +13

Human Epidermal Growth Factor Receptor 2 Status Correlates With Lymph Node Involvement in Patients With Estrogen Receptor (ER) –Negative, but With Grade in Those With ER-Positive Early-Stage Breast Cancer Suitable for Cytotoxic Chemotherapy

John M.S. Bartlett, Ian O. Ellis, Mitch Dowsett et al. · Journal of Clinical Oncology · 2007 · 67 citations

Medicine, Oncology, Chemotherapy +14

Purinergic Receptor Expression and Cellular Responses to Purinergic Agonists in Human Prostate Cancer Cells

Kornkamon Lertsuwan, Wachen Peters, Lindsay Johnson et al. · Anticancer Research · 2017 · 15 citations · Full text

Medicine, Oncology, Pharmacology +15

Auditors' Perceptions of the PCAOB Inspection Process

Lindsay Johnson, Marsha B. Keune, Jennifer Winchel · SSRN Electronic Journal · 2015 · 11 citations · Full text

Business, Accountancy, Accounting +13

1–4 of 4